Board approved Reclassification request received to change the status from Promoter Group Shareholder to Public Shareholder
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Chemo Pharma Laboratories Ltd, at its meeting on August 22, 2025, approved a request from Ms. Shanta Somani to be reclassified from the 'Promoter Group' category to the 'Public' category under SEBI Regulation 31A. The applicant currently holds NIL shares in the company and has no direct or indirect control over company affairs, nor any board/KMP position. The reclassification is subject to approval from BSE and other regulatory authorities. The company confirmed it meets the minimum public shareholding requirement under Regulation 38, its shares are not suspended from trading, and there are no outstanding dues to SEBI, stock exchanges, or depositories. The change will be reflected in the shareholding pattern from the immediate next quarter once approvals are received.
This is a procedural housekeeping change with minimal impact on shareholders — the applicant holds zero shares, so promoter group shareholding levels remain unchanged and there is no effect on stock price or voting rights.